Skip to content
10-Q

Quarterly Report

ACTAVIA LIFE SCIENCES, INC.

0001213900-23-039553

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · May 15, 2023 771.81M sh
Current Liabilities Q2 2023 · Mar 31, 2023 $1.92M
Current Liabilities Q2 2023 · Sep 30, 2022 $1.68M
Total Liabilities Q2 2023 · Mar 31, 2023 $1.92M
Total Liabilities Q2 2023 · Sep 30, 2022 $1.77M
Total Assets Q2 2023 · Mar 31, 2023 $52.3K
Total Assets Q2 2023 · Sep 30, 2022 $85.28K
Shares Diluted Q2 2023 · Mar 31, 2022 170.04M sh
Shares Diluted Q2 2023 · Mar 31, 2022 163.24M sh
Operating Cash Flow Q2 2023 · Mar 31, 2022 −$142.77K
Stockholders Equity Q2 2023 · Mar 31, 2022 −$2.14M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$2.5M
Stockholders Equity Q2 2023 · Sep 30, 2021 −$2.75M
Eps Diluted Q2 2023 · Mar 31, 2022 $0.00
Eps Diluted Q2 2023 · Mar 31, 2022 $0.00
Eps Basic Q2 2023 · Mar 31, 2022 $0.00
Eps Basic Q2 2023 · Mar 31, 2022 $0.00
Sga Expense Q2 2023 · Mar 31, 2022 $126.04K
Sga Expense Q2 2023 · Mar 31, 2022 $198.7K
Rd Expense Q2 2023 · Mar 31, 2022 $17.22K
Rd Expense Q2 2023 · Mar 31, 2022 $26.36K
Net Income Q2 2023 · Mar 31, 2022 $293.99K
Net Income Q2 2023 · Mar 31, 2022 $19.36K
Operating Income Q2 2023 · Mar 31, 2022 $381.74K
Operating Income Q2 2023 · Mar 31, 2022 $299.94K